THBS2 Is a Candidate Modifier of Liver Disease Severity in Alagille Syndrome

Ellen Tsai, Melissa A. Gilbert, Christopher M. Grochowski, Lara A. Underkoffler, He Meng, Xiaojie Zhang, Michael M. Wang, Hailu Shitaye, Kurt D. Hankenson, David A. Piccoli,

Cellular and Molecular Gastroenterology and Hepatology · 2016 · 50 citations · 39 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND & AIMS: , resulting in bile duct paucity, cholestasis, cardiac disease, and other features. Liver disease severity in Alagille syndrome is highly variable, however, factors influencing the hepatic phenotype are unknown. We hypothesized that genetic modifiers may contribute to the variable expressivity of this disorder. METHODS: mutations, comparing patients with mild vs severe liver disease, followed by functional characterization of a candidate locus. RESULTS: -null mouse livers showed increased microvessels in the portal regions of adult mice. We also showed that thrombospondin 2 interacts with NOTCH1 and NOTCH2 and can inhibit JAG1-NOTCH2 interactions. CONCLUSIONS: as a plausible candidate genetic modifier of liver disease severity in Alagille syndrome.

References

39